Haze testing is a critical quality control measure for transparent and translucent medical packaging materials, quantifying the light-scattering properties that govern product visibility, content inspection, and overall optical clarity. This technical article explores the principles, applicable standards, sample types, testing procedures, and practical applications of haze inspection for pharmaceutical and medical device packaging. By understanding haze measurement, manufacturers can verify material quality, support sterilization and stability validation, and maintain the optical performance required for safe product identification.
Technical Overview
Haze, in the context of transparent plastic materials, is defined as the percentage of transmitted light that is scattered by more than 2.5 degrees from the direction of the incident beam, relative to the total transmitted light. In medical packaging, haze is a key optical performance indicator because packaging must allow clear visual inspection of contents—such as tablets, capsules, syringes, catheters, and surgical instruments—without opening the sterile barrier. High haze reduces image contrast, blurs the view of the product inside, and may interfere with automated visual inspection or barcode scanning of labeled contents.
Excessive haze can also signal underlying material problems, including surface contamination, crystallization, poor dispersion of additives, processing defects in extrusion or thermoforming, or degradation caused by sterilization and aging. For these reasons, haze measurement is routinely integrated into incoming material inspection, sterilization validation, and shelf-life stability studies for medical packaging.
The most widely recognized standards for haze measurement include:
- ASTM D1003 — Standard Test Method for Haze and Luminous Transmittance of Transparent Plastics
- ISO 14782 — Plastics: Determination of Haze for Transparent Materials
- GB/T 2410 — Determination of Light Transmittance and Haze of Transparent Plastics
- GB/T 14216 — Determination of Haze of Plastic Film and Sheeting
- JIS K 7136 / JIS K 7361 — Japanese standards for haze and total luminous transmittance of plastics
Testing is typically performed by manufacturers' internal quality laboratories or by accredited third-party laboratories using calibrated hazemeters or spectrophotometers equipped with integrating spheres.
Testing Samples
Rigid Sheets for Blister Packaging
Rigid and semi-rigid plastic sheets used in thermoformed blister packs, including PVC, PVDC-coated PVC, PVC/PVDC laminates, PETG, cyclic olefin copolymer (COC), and polypropylene (PP). Specimens are cut from flat areas of the unformed sheet or from formed blister cavities when post-forming optical performance must be evaluated.
Flexible Films and Laminates for Pouches
Multi-layer laminated films used in sterile barrier pouches and bags, such as PET/PE, PA/PE, PET/AL/PE transparent windows, and transparent laminates combined with breathable materials. Flat, wrinkle-free specimens representative of production lots are required.
Thermoformed Tray Lid Stock
Transparent lid films and rigid transparent lids used with thermoformed trays for medical device packaging, where unobstructed visualization of the device and any tamper indicators is essential.
Tubing Films and Bag Materials
Films used in infusion bags, parenteral nutrition containers, and fluid-path components, where optical clarity supports visual checks for particulates, fill level, and solution condition.
Specimen Conditioning
Prior to testing, specimens are typically conditioned at 23 ± 2 °C and 50 ± 5% relative humidity for a minimum of 40 hours, in accordance with ASTM D618 or ISO 291, unless otherwise specified. Specimens must be free of fingerprints, scratches, wrinkles, and surface contamination, and thickness must be measured and reported because haze values are thickness-dependent.
Testing Items
The core optical parameters evaluated in medical packaging haze testing include:
- Haze — the percentage of transmitted light deviating more than 2.5 degrees from the incident beam, expressed relative to total transmitted light
- Total luminous transmittance — the ratio of transmitted light to incident light, weighted for the photopic response of the human eye (CIE standard illuminant A or D65, depending on the standard applied)
- Diffuse transmittance — the scattered component of transmitted light, from which haze is derived
- Parallel transmittance — the unscattered component that passes directly through the specimen, relevant to image-forming clarity
- Haze after sterilization or aging — comparative measurements before and after exposure to ethylene oxide, gamma or electron-beam irradiation, steam sterilization, or accelerated aging conditions
Testing Methods
Hazemeter Method (ASTM D1003, Method A)
A hazemeter uses a regulated light source, a photodetector, and an integrating sphere with a light trap. Four successive measurements are taken: incident light (T1), total light transmitted by the specimen (T2), light scattered by the instrument (T3), and light scattered by instrument plus specimen (T4). Total transmittance is calculated as T2/T1, and haze is calculated as [(T4 − T3)/T2] × 100%. This method is fast, direct, and well suited to routine quality control.
Spectrophotometer Method (ASTM D1003, Method B)
A spectrophotometer fitted with an integrating sphere measures transmittance over the visible spectrum. Measured spectral data are mathematically weighted to calculate luminous transmittance and haze. This method provides greater optical versatility and is useful when spectral information about scattering behavior is needed.
Standard Test Procedure
- Cut at least five specimens from representative locations across the sample, avoiding defects and printed areas; typical specimen sizes are 50 mm × 50 mm or discs matched to the instrument aperture
- Condition specimens to the specified atmosphere and record the thickness of each specimen at multiple points
- Calibrate and zero the instrument using certified reference standards traceable to national metrology institutes
- Place each specimen flush against the integrating sphere port, ensuring no air gaps or bending, and record haze and transmittance values
- Report the individual and mean values, specimen thickness, test standard used, illuminant, and instrument type
For materials with light-transmitting matte or textured surfaces, unidirectional or luminous haze measurement procedures described in the applicable standards should be followed, and the test direction relative to machine direction should be documented.
Applications
Haze testing for medical packaging supports quality assurance and regulatory compliance across the product lifecycle:
- Incoming material acceptance — verifying that purchased films, sheets, and laminates meet optical specifications before conversion into blister packs, pouches, or trays
- Sterilization validation — assessing whether ethylene oxide, gamma, electron-beam, or moist heat sterilization causes haze increase, yellowing, or loss of clarity in the sterile barrier system
- Stability and shelf-life studies — monitoring haze change during real-time and accelerated aging in accordance with ISO 11607-1 requirements for sterile barrier performance
- Process optimization — evaluating the effect of extrusion conditions, thermoforming parameters, coating thickness, and additive formulations on optical quality
- Comparative material selection — benchmarking candidate polymers such as PVC, PETG, COC, and PP for clarity-critical packaging applications
- Failure analysis — investigating customer complaints or visual defects by comparing haze levels between conforming and non-conforming lots
Manufacturers submitting packaging systems for regulatory review frequently include haze and transmittance data from accredited third-party laboratories as objective evidence of material quality and consistency.
FAQ
What is haze in medical packaging, and why does it matter?
Haze is the percentage of transmitted light scattered away from the incident beam direction. In medical packaging, low haze ensures that clinicians, pharmacists, and patients can clearly inspect the contents—verifying product identity, quantity, integrity, and absence of visible defects—without compromising the sterile barrier.
Which standards govern haze testing for medical packaging materials?
The principal standards are ASTM D1003, ISO 14782, GB/T 2410, GB/T 14216, and the JIS K 7136 / JIS K 7361 series. Selection depends on the target market, material form (film versus rigid sheet), and customer or regulatory specifications.
What haze value is considered acceptable for medical packaging?
Acceptance limits are defined by the packaging specification rather than a universal threshold. Clear rigid blister materials commonly target haze values below 2–3%, while flexible laminates may permit higher values depending on structure and end use. Values should always be evaluated against thickness and the specific product requirements.
Does sterilization increase haze?
Certain sterilization processes can affect optical properties. Gamma and electron-beam irradiation may induce color change or increased scattering in some polymers, and repeated thermal cycling can alter crystallinity. Haze testing before and after sterilization is therefore a standard component of packaging validation.
How is haze different from luminous transmittance and clarity?
Transmittance measures how much light passes through the material, haze measures how much of that light is broadly scattered, and clarity describes the ability to see distinct images through the material. A material can transmit a high percentage of light while exhibiting high haze, resulting in a milky appearance and poor see-through quality.
